Abstract:Minghao Gu, 1, 2 SenSen Lv, 1 Yihui Song, 3 Hong Wang, 4 Xingyu Zhang, 5 Jing Liu, 1 Deshun Liu, 1 Xiudi Han, 1 Xuedong Liu 1 1 Department of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, 266011, People's Republic of China; 2 School of Medicine, Qingdao University, Qingdao, 266071, People's Republic of China; 3 Department of Neurology, Weihai Municipal Hospital, Weihai, 264200, People's Republic of China; 4 Hospital-Acquired Infection Control Department, Qingdao Municipal Hospital, Qingdao, 266011, People's Republic of China; 5 Human Resources Department, Qingdao Municipal Hospital, Qingdao, 266011, People's Republic of China Correspondence: Xuedong Liu; Xiudi Han, Department of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, 266011, People's Republic of China, Email ; Purpose: To investigate the clinical value of serum lysophosphatidylcholine (LPC) as a predictive biomarker for determining disease severity and mortality risk in hospitalized elderly patients with community-acquired pneumonia (CAP). Methods: This prospective, single-center study enrolled 208 elderly patients, including 67 patients with severe CAP (SCAP) and 141 with non-SCAP between November 1st, 2020, and November 30th, 2021 at the Qingdao Municipal Hospital, Shandong Province, China. The demographic and clinical parameters were recorded for all the included patients. Serum LPC levels were measured on day 1 and 6 after admission using ELISA. Propensity score matching (PSM) was used to balance the baseline variables between SCAP and non-SCAP patient groups. Receiver operative characteristic (ROC) curve analysis was used to compare the predictive performances of LPC and other clinical parameters in discriminating between SCAP and non-SCAP patients and determining the 30-day mortality risk of the hospitalized CAP patients. Univariate and multivariate logistic regression analyses were performed to identify the independent risk factors associated with SCAP. Cox proportional hazard regression analysis was used to determine if serum LPC was an independent risk factor for the 30-day mortality of CAP patients. Results: The serum LPC levels at admission were significantly higher in the non-SCAP patients than in the SCAP patients (P = 0.011). Serum LPC level < 24.36 ng/mL, and PSI score were independent risk factors for the 30-day mortality in the elderly patients with CAP. The risk of 30-day mortality in the elderly CAP patients with low serum LPC levels ( 5-fold higher than in the patients with high serum LPC levels (≥ 24.36ng/mL). Conclusion: Low serum LPC levels were associated with significantly higher disease severity and 30-day mortality in the elderly patients with CAP. Therefore, serum LPC is a promising predictive biomarker for the early identification of elderly CAP patients with poor prognosis. Keywords: lysophosphatidylcholine, community-acquired pneumonia, biomarker, severity, mortality, propensity score matching Community-acquired pneumonia (CAP) is a common infectious respiratory disease that is associated with high morbidity and mortality rates, especially in patients with severe co-morbidities. 1 In patients with severe community-acquired pneumonia (SCAP), the mortality rate is >35% for those with septic shock and requiring mechanical ventilation; mortality rate is >30% for those who develop acute respiratory distress syndrome. 2 The advanced age and underlying disease in the elderly CAP patients is associated with higher mortality rates, the need of intensive care, and increased disease burden. 3,4 Currently, the early clinical diagnosis and assessment of CAP severity is based on the pneumonia severity index (PSI) score 5 and the CURB-65 score. 6 However, these methods are not effective in predicting the morbidity and mortality outcomes of the elderly SCAP patients. 4,7,8 Biomarkers such as C-reactive protein (CRP), 9 procalcitonin (PCT), 10 and interleukin-6 (IL-6) 11 can be measured with high accuracy in the blood samples and are widely used to assess the severity of adverse outcomes. Several studies have demonstrated that CRP, PCT, and IL-6 are potential prognostic risk factors in CAP patients. 12,13 Lysophosphatidylcholine (LPC) is a core component of the cellular membranes and is the most abundant lysophospholipid in human blood. LPC activates immune cells such as monocytes, macrophages, T-lymphocytes, and neutrophils by binding to the G protein-coupled receptors (GPCRs) 14 and toll-like recept -Abstract Truncated-

CD4+ T cells related to disease severity in elderly and frailty community‐acquired pneumonia patients: A retrospective cohort study

Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia

Serum Procalcitonin, White Blood Cell and Hypersensitive C-reactive Protein Combined with Age Established a New Prediction Model in Predicting ICU Admission in Adult Community-Acquired Pneumonia (CAP) Patients.

T Cell Responses in Senior Patients with Community-Acquired Pneumonia Related to Disease Severity.

Clinical features and prognostic factors of elderly patients with severe community-acquired pneumonia

Relationship between T lymphocyte counts and severity of pneumonia

Analysis of etiology and prognostic factors of community acquired pneumonia in elderly patients

Analysis of prognostic factors for hospitalized patients aged 95 years and over with community-acquired pneumonia

Predictive value of community-acquired pneumonia severity scores on lung cancer patients with immune checkpoint inhibitor-associated pneumonitis: a retrospective analysis

Change and correlation analysis of prognosis of C reactive protein and procalcitonin in the elderly patients with severe pneumonia

Correlation between composite infections in acquired immune deficiency syndrome patients complicated with pneumocystis pneumonia and counts of CD4 + T cell

Clinical Analysis of 44 Patients with Community-Acquired Pneumonia in Very Elderly

Relationship between Cellular Immunity Changes and Prognosis in Elderly Patients with Sepsis

Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network

Dynamic expression of Toll-like receptor 2 and 4 on blood monocytes in the elderly patients with severe pneumonia and their clinical significance

Clinical value of serum procalcitonin and C-reactive protein levels in elderly patients with community acquired pneumonia

Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients

Exploration of Aging-Care Parameters to Predict Mortality of Patients Aged 80-Years and Above with Community-Acquired Pneumonia

Predictive Value of Lysophosphatidylcholine for Determining the Disease Severity and Prognosis of Elderly Patients with Community-Acquired Pneumonia

[Association between CD4+T lymphocyte and body composition with physical frailty among elderly HIV-infected patients in Chongqing City]

B cell subsets were associated with prognosis in elderly patients with community acquired pneumonia